Last update:

Laboratory medicine news

Updated guidelines standardize how tumor response is measured after surgery

Researchers at the Johns Hopkins Kimmel Cancer Center and its Bloomberg~Kimmel Institute for Cancer Immunotherapy have released updated consensus guidelines and an associated reproducibility study to standardize how pathologists ...

How our lab is helping develop an Alzheimer's test that can be done at home

Imagine diagnosing one of the most challenging neurological diseases with just a quick finger-prick, a few drops of blood and a test sent in the post. This may sound like science fiction, but we are hoping our research could ...

Early signs of Parkinson's can be identified in the blood

A team led by researchers at Chalmers University of Technology, Sweden, has succeeded in identifying biomarkers for Parkinson's disease in its earliest stages, before extensive brain damage has occurred. The biological processes ...

A skin biopsy can detect a rare neurodegenerative disease

By determining the structure of the deposits responsible for transthyretin amyloidosis through a simple skin biopsy, scientists at UNIGE are paving the way for a new diagnostic method for neurodegenerative diseases. Transthyretin ...

AI can predict preemies' paths based on blood spot data

An artificial intelligence-based tool can predict the medical trajectories of individual premature newborns from blood samples collected soon after they are born, a Stanford Medicine-led study has shown.

Virtual histography: From tissue section to 3D image

Histology is one of the foundations of modern diagnostics. When physicians want to determine whether tissue is pathologically altered, they rely on microscopic tissue analysis: They cut the tissue into ultrathin sections, ...

Blood test reveals risk of multimorbidity in older adults

A small set of common blood biomarkers predicts which older adults will develop specific combinations of chronic diseases—and how quickly, according to a new study from Karolinska Institutet published in Nature Medicine.

Costs pose hurdle for promising new hepatitis C lab test

A new rapid test for hepatitis C could help identify many more patients who could be cured of the deadly disease, but its use may be limited unless insurers' reimbursement rises to cover its high cost, according to researchers ...